What is Morgan Stanley's indefinite-lived research and development assets?

Morgan Stanley (MS) reported indefinite-lived research and development assets of $2.12B in Q4 2025.

What is the long-term trend for Morgan Stanley's indefinite-lived research and development assets?

Over 3 years (2022 to 2025), Morgan Stanley's indefinite-lived research and development assets has grown at a 0.1% compound annual growth rate (CAGR), from $2.11B to $2.12B.

Non-Current Assets

Indefinite-Lived Research and Development Assets

Morgan Stanley Indefinite-Lived Research and Development Assets increased by 0.2% to $2.12B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Indefinite-Lived Research and Development Assets shows relatively stable performance with a 0.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryGrowth

SignalHigher is better

VolatilityModerate

First reportedQ4 2022

Last reportedQ4 2025Feb 19, 2026

How to read this metric

An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.

Detailed definition

This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...

Peer comparison

Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.

Metric ID: indefinite_lived_rd_assets

Historical Data

4 periods

	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$2.11B	$2.11B	$2.11B	$2.12B
QoQ Change	—	+0.1%	-0.0%	+0.2%
YoY Change	—	+0.1%	-0.0%	+0.2%

Range$2.11B – $2.12B

Avg YoY Growth+0.1%

Median YoY Growth+0.1%

Indefinite-Lived Research and Development Assets at Other Companies

Robinhood Markets, Inc.HOOD View metric

BlackrockBLK View metric

Frequently Asked Questions

What is Morgan Stanley's indefinite-lived research and development assets?: Morgan Stanley (MS) reported indefinite-lived research and development assets of $2.12B in Q4 2025.
What is the long-term trend for Morgan Stanley's indefinite-lived research and development assets?: Over 3 years (2022 to 2025), Morgan Stanley's indefinite-lived research and development assets has grown at a 0.1% compound annual growth rate (CAGR), from $2.11B to $2.12B.
What does indefinite-lived research and development assets mean?: The value of ongoing research projects acquired from other companies that are not yet ready for sale.